HSBC may have to `pay more'' for 14.7 per cent in UTI Bank
By New Delhi: | 17 Dec 2003
New Delhi: The HSBC group may have to pay a higher price than the Rs 306-crore to CDC Financial Services (Mauritius) Ltd (CDC-FSL) and the South Asia Regional Fund for buying out their combined 14.7 per cent stake in the UTI Bank in case they revise their open offer price to a level higher than the acquisition price of Rs 90 per share.
A clause to this effect has been included in HSBC's application to the Foreign Investment Promotion Board to seek clearance for the transaction.
This is because the buy-out agreement includes such a condition and the transaction has been completed at a price of Rs 90 per share. "In case HSBC Asia Pacific Holdings (UK) Ltd acquires shares in the open offer at a price higher than Rs 90 per share of UTI Bank, such higher price would be payable to CDC-FSL and SARF for the shares being acquired under the agreement and as per the options," the application has said.
.jpg "RBI keeps repo rate unchanged as focus remains on inflation")
.jpg "Indian Oil, Panasonic team up for lithium-ion cell production in India")
